Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN
Abroad (travel likely)RecruitingPHASE2
Conditions
Primary/Secondary Prevention · High Risk for Febrile Neutropenia of Chemotherapy Regimens · Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in Febrile Neutropenia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The Henan cancer hospital, Zhengzhou, Henan, China